Tretinoin
Topical retinoid all-trans-retinoic acid. Acne, photoaging, hyperpigmentation treatment. Dermatological gold standard.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.
Related comparisons
Tretinoin vs Tazarotene vs Azelaic acidDETAILED OVERVIEW
What is Tretinoin?
Tretinoin (all-trans-retinoic acid) is the first topical retinoid (Ortho Retin-A, FDA 1971), dermatological standard in acneology + anti-aging. Retinoid receptor (RAR) activation normalizes follicular keratinization (acne mechanism), accelerates collagen synthesis (anti-aging), and reduces melanin pigmentation (hyperpigmentation). The most common strengths: 0.025%, 0.05%, 0.1% cream or gel. Compared with isotretinoin it is topical – non-systemic, pregnancy risk SIGNIFICANTLY LOWER, but avoid in childbearing-age women. Long-term anti-aging evidence: Kligman 1986 PMID 3548421, the best-documented topical treatment for photoaging.
ATC code
D10AD01
Prescription status
Prescription only (Rx), dermatologist supervision
Mechanism of action
RAR-α/β/γ retinoid receptor agonist (all-trans-retinoic acid)
Half-life
Topical, minimal systemic absorption
Onset of action
8-12 weeks (acne), 4-6 months (anti-aging)
Anecdotal reports describe Tretinoin as one of the most potent topical treatments for facial acne and overall skin quality. Initial irritation – redness, breakouts, peeling – typically occurs in the first month and resolves with continued use. The best effects are delayed: collagen-related improvements and texture changes appear after several months of consistent application. Community accounts note that Tretinoin may enhance the penetration of adjunct skincare topicals, though this is largely anecdotal. It has a narrower therapeutic window than cosmetic retinoids – most users find a stable concentration without needing to escalate. Caution: photosensitivity is significant; daily SPF is mandatory. The pregnancy contraindication applies.
⚠ Not clinical evidence – based on user accounts.
Data console
Lab data
Balado-Simó P, Morgado-Carrasco D, Gómez-Armayones S . An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer.. J Clin Med.
Eichenfield DZ, Sprague J, Eichenfield LF . Management of Acne Vulgaris: A Review.. JAMA.
Hu H, Zhou P, Yao H . Efficacy and Safety of Generic Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream Compared With TRI-LUMA for the Treatment of Melasma.. J Cosmet Dermatol.
Safety
Side effects, stop signs, contraindications
Side effects · 6
- Skin irritation: redness, burning-stinging, dryness and peeling, mainly in the first weeks of treatment (retinization phase).
- Increased photosensitivity (phototoxicity) and tendency to sunburn, so daily SPF 30+ sun protection is mandatory.
- Initial acne flare-up (purging) in the first 2–4 weeks before the skin improves.
- Transient hyper- or hypopigmentation, plus a tight, sensitive feeling on the treated area.
- Contact dermatitis, severe peeling or blistering with excessive amounts or too-frequent application.
- On eczematous, sunburned or broken skin: heightened irritation, stinging and dryness.
Contraindications · 3
- Pregnancy (retinoid)
- Broken/sunburned skin
- Hypersensitivity
Related Hair & Skin
Same therapeutic category
Studies
Related research and clinical findings
An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer.
Balado-Simó P, Morgado-Carrasco D, Gómez-Armayones S
Management of Acne Vulgaris: A Review.
Eichenfield DZ, Sprague J, Eichenfield LF
Efficacy and Safety of Generic Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream Compared With TRI-LUMA for the Treatment of Melasma.
Hu H, Zhou P, Yao H
Telegram
Have a question about Tretinoin?
Educational hair and skin info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation. Talk to a dermatologist!
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.